Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03877276
Other study ID # F151123009
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date July 21, 2016
Est. completion date December 1, 2024

Study information

Verified date December 2023
Source University of Alabama at Birmingham
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate mitochondrial function in white blood cells and platelets from healthy individuals following dietary oxalate intake.


Description:

Inflammation and dietary oxalate have been shown to play an important role in the development of kidney stones. Oxalate is a small molecule found in plants and plant-derived food. Individuals that have high oxalate intake have an increased risk of developing kidney stones. The co-investigators have previously shown that healthy subjects that consume dietary oxalate have increased plasma and urine oxalate. White blood cells are essential for the immune response and rely on the mitochondria to carry out important cell functions. The Principal Investigator's current research shows that patients with calcium oxalate kidney stones have decreased mitochondrial function in their immune cells. Using the expertise of the investigators, this study will test whether oxalate has a direct effect on mitochondrial function in immune cells from healthy subjects. This information could help us understand the role of oxalate on the immune system during kidney stone pathogenesis.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 82
Est. completion date December 1, 2024
Est. primary completion date June 1, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: - Mentally competent adults who are able to read and comprehend the consent form, written in English - Male or Female - Age 18 to 70 years - Non-tobacco users - BMI between 19 and 27 - Willingness to abstain from vigorous exercise during study period - Normal blood comprehensive metabolic panel Exclusion Criteria: - Mentally incompetent adults who are unable to read or comprehend the consent form, written in English - Pregnant females - Active medical problems - History of kidney stones - Any medical disorder that could influence absorption or excretion of oxalate - BMI less than 19 or greater than 27 - Tobacco users - Current use of medications or dietary supplements

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Breakfast
a prepared meal consisting of pastry and 2 cooked egg whites
Spinach smoothie
a prepared blended spinach smoothie, consisting of banana, avocado, orange juice, and spinach
Kale smoothie
prepared blended kale smoothie, consisting of banana, avocado, orange juice, and kale
Blended smoothie
a prepared blended smoothie, consisting of banana, avocado, and orange juice
V spinach smoothie
a prepared blended spinach smoothie, consisting of banana, avocado, orange juice, and a varying amount (low, medium, high) of spinach
Sodium oxalate drink
a prepared sodium oxalate drink

Locations

Country Name City State
United States University of Alabama at Birmingham Birmingham Alabama

Sponsors (1)

Lead Sponsor Collaborator
University of Alabama at Birmingham

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in monocyte cellular energetics after 5 hours Cellular bioenergetics (oxygen consumption rate) will be measured in isolated monocytes from human blood using a Seahorse XF Analyzer machine. Monocyte cellular bioenergetics will be measured before and after consuming a spinach smoothie (pre- and post-loads; Time 0 hours and 5 hours) to assess a change in monocyte cellular energetics after 5 hours. 0 hours - 5 hours
See also
  Status Clinical Trial Phase
Recruiting NCT04495699 - Asymptomatic Renal Calculi in Recurrent Urinary Tract Infections
Recruiting NCT04559321 - Holmium Vs Trilogy Kidney Stones GUY's 1-2 Phase 3
Completed NCT04332861 - Evaluation of Infection in Obstructing Urolithiasis
Recruiting NCT06138327 - A Study of BMN 255 in Participants With Non-Alcoholic Fatty Liver Disease And Hyperoxaluria Phase 1
Completed NCT03872843 - Opioid Free Management After Ureteroscopy Phase 4
Recruiting NCT04997668 - Clinical Outcomes and Healthcare Economics of SOLTIVE Compared to Ho:YAG Laser in Urolithiasis N/A
Active, not recruiting NCT04333745 - Influence of Obesity on Oxalate Metabolism and Handling in Calcium Oxalate Stone Formers N/A
Recruiting NCT05701098 - SOUND Pivotal Trial - (Sonomotion stOne comminUtion resoNance ultrasounD) N/A
Recruiting NCT04389853 - Mini-PNCL vs fURS in Management of Nephrolithiasis N/A
Recruiting NCT05334979 - Oxalate and Citrate N/A
Recruiting NCT05591716 - Evaluation of the Efficacy and Safety of Unimodal Bilateral Flexible Ureteroscopy. N/A
Recruiting NCT06209931 - RIRS With Tip Flexible Pressure-controlling Ureteral Access Sheath Versus Mini PCNLfor Kidney Stones
Withdrawn NCT04545528 - The Impact of Nutritional Service in the Stone Clinic on the Patient Urine Collection Results
Completed NCT05714423 - Outcomes in Lower Pole Kidney Stone Management Using Mini-PCNL Compared With Retrograde Intra Renal Surgery N/A
Recruiting NCT03281928 - Effect of Dietary Sodium and Potassium Citrate on Renal Mineral Handling N/A
Recruiting NCT04835922 - Comparison of Efficacy of Intercostal Nerve Block vs Peritract Infiltration With 0.25% Bupivacaine in PCNL N/A
Recruiting NCT03257306 - Magnetic Ureteral Stent Symptoms - a Comparison to Standard Ureteral Stent as Perceived By the Patient (MAGUSS) N/A
Not yet recruiting NCT05504512 - Percutaneous Nephroscopic Treatment of Parapelvic Cysts
Recruiting NCT06306222 - Thulium Fiber Laser vs. Holmium:YAG Laser for the Ureteroscopic Treatment of Patients With Urinary Stone Disease N/A
Not yet recruiting NCT04606758 - Fluoroscopic Guided vs US-guided Percutaneous Nephrolithotripsy for the Treatment of Stone Disease N/A